Exciva
Entry
2019
Hold
7yr
Status
Active
Who owns Exciva?
Exciva is a Belgian Biotech company, currently owned by LifeArc since 2026 and 3 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYMost recent investor
Andera PartnersBioDiscovery 5 · 2017 · VC
4 ownership periods · full history below
Key facts
HQBelgium
SectorBiotech
Key takeaways
- ·Co-held by Andera Partners, LBBW Venture Capital, LifeArc and Gimv since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
Andera PartnersActive
2019 · present(7yr) · BioDiscovery 5 · 2017 · VC
LBBW Venture CapitalActive
2021 · present(5yr) · LBBW VC Evergreen Vehicle · 1998 · VC
LifeArcActive
2026 · present(<1yr) · LifeArc Ventures · 1992 · Life Sciences VC
GimvActive
present · Gimv Portfolio
More from BioDiscovery 5
Other portfolio companies in the same fund.
Amolyt Pharma
Exited 2024
Biotech
France· 2021
to AstraZeneca
Evommune
Exited 2025
Biotech
France· 2021
to Public market (NYSE IPO ticker EVMN)
Nyxoah
Active
MedTech
Belgium· 2020
AgoMab
Exited 2026
Biotech
France· 2019
to Public market (Nasdaq IPO ticker AGMB)
AM Pharma
Active
Biotech
Netherlands· 2019
Arvelle
Exited 2021
Biotech
Switzerland· 2019
to Angelini Pharma
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Exciva?
Exciva is currently owned by LifeArc, LBBW Venture Capital and 2 others, through BioDiscovery 5, since 2026.
When did LifeArc and 3 others acquire Exciva?
LifeArc and 3 others acquired Exciva in 2026.
Who has owned Exciva over time?
Exciva has been through 4 private-equity ownership periods: Andera Partners · via BioDiscovery 5 · since 2019; LBBW Venture Capital · via LBBW VC Evergreen Vehicle · since 2021; LifeArc · via LifeArc Ventures · since 2026; Gimv.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue